# Financing adjudication

This review uses only the authorized instruction, two filings, and five candidate JSON files. It does not change candidates.

## Rules that control both questions

- **Part B, line 28:** Later evidence within the bid's window can describe its original state. A later change cannot recode that state. The window ends at the next specified event, which includes execution of the agreement.
- **E10, line 261:** A Same-offer row copies the earlier offer, but permits “any condition the filing reports anew.” Copying does not prevent a supported financing update.
- **E10, line 253:** A price revision uses its own communication and evidence window. It does not inherit every earlier condition.
- **E12, lines 285–288:** Silence is Not stated. No financing condition supports Committed. Cash on hand or existing facilities support Not needed. The explicit absence of a firm financing arrangement triggers Contingent, even with no financing condition.

Rule locations: [Part B](/home/uctpiaj/work/Projects/sec-auction/SEC_Deal_Ledger_Extraction_Instruction.md:28), [E10](/home/uctpiaj/work/Projects/sec-auction/SEC_Deal_Ledger_Extraction_Instruction.md:253), [E12](/home/uctpiaj/work/Projects/sec-auction/SEC_Deal_Ledger_Extraction_Instruction.md:285).

## Q1: Penford

**Uphold the omission of stated financing information. Do not assert that the agreement alone proves a uniquely required Not needed code.**

The affected entries are A, ledger #42, Excel row 43, and B, ledger #47, Excel row 48. Both record the October 14 reaffirmation at $19.00 with Financing = Not stated.

The source sequence is decisive:

1. Ingredion confirms $19.00 on October 14. The parties then exchange further drafts. See printed p. 32, [HTML lines 2735–2737](/home/uctpiaj/work/Projects/sec-auction/raw_filing/penford_2014-12-29_DEFM14A.htm:2735).
2. The board reviews the terms and approves the agreement before evening execution. See printed pp. 32–33, [HTML lines 2741–2765](/home/uctpiaj/work/Projects/sec-auction/raw_filing/penford_2014-12-29_DEFM14A.htm:2741).
3. The reasons section expressly describes factors behind that approval. One factor states: “Ingredion’s obligation to consummate the merger is not subject to any financing condition.” See printed pp. 33–34, [the introduction](/home/uctpiaj/work/Projects/sec-auction/raw_filing/penford_2014-12-29_DEFM14A.htm:2766) and [the factor](/home/uctpiaj/work/Projects/sec-auction/raw_filing/penford_2014-12-29_DEFM14A.htm:2842).

Thus, a dated account before execution supplies financing evidence within the final reaffirmation's window. It reports no later financing change. Part B permits this evidence. E10 expressly permits the newly reported condition. **Committed is directly supported; Not stated misses that evidence.**

The agreement supplies additional support, with a narrower timing limit. Section 4.6 says Parent has sufficient available funds or access under existing credit agreements “as of the date of this Agreement.” The agreement date is October 14. See printed p. A-1, [HTML line 8348](/home/uctpiaj/work/Projects/sec-auction/raw_filing/penford_2014-12-29_DEFM14A.htm:8348), and p. A-24, [HTML lines 9101–9103](/home/uctpiaj/work/Projects/sec-auction/raw_filing/penford_2014-12-29_DEFM14A.htm:9101).

That representation supports Not needed if the date-level statement supplies evidence for the final bid. It does not expressly fix the intraday state at the earlier call. The rule also gives no express priority between the overlapping Committed and Not needed definitions here. The omission finding needs neither assumption: the board's reason already supports Committed before execution.

Do not extend these facts to the October 8 or earlier bids. Their windows end before the dated financing evidence.

## Q2: Medivation

**Do not uphold a confirmed requirement to change C's final bid to Contingent. Record the timing issue and conditional E12 conflict.**

The affected entry is C, ledger #23, Excel row 24, dated August 20, with price $81.50. Financing is Committed. Its Note cites the signed agreement's lack of a financing condition, available funds, and no financing commitment.

The relevant source passages differ in their time reference:

- The August 8 proposal explicitly lacks a financing condition. This fact belongs to that proposal. See printed p. 23, [HTML lines 1492–1494](/home/uctpiaj/work/Projects/sec-auction/_dev/cockpit/state/filings/medivation/medivation_2016-08-30_SCTO-T.htm:1492).
- The August 20 account reports $81.50, board approval, then afternoon execution. It reports no financing state for that bid. See printed p. 24, [HTML lines 1518–1521](/home/uctpiaj/work/Projects/sec-auction/_dev/cockpit/state/filings/medivation/medivation_2016-08-30_SCTO-T.htm:1518).
- Section 9 says Pfizer and Purchaser “currently have, and will have” all necessary funds through several sources, including cash. It also says Pfizer entered no financing commitment. See printed p. 21, [HTML lines 1429–1431](/home/uctpiaj/work/Projects/sec-auction/_dev/cockpit/state/filings/medivation/medivation_2016-08-30_SCTO-T.htm:1429).
- The summary combines that funds disclosure with no financing condition. See printed p. 2, [HTML lines 450–455](/home/uctpiaj/work/Projects/sec-auction/_dev/cockpit/state/filings/medivation/medivation_2016-08-30_SCTO-T.htm:450). The Offer to Purchase bears August 30, ten days after execution: [HTML line 64](/home/uctpiaj/work/Projects/sec-auction/_dev/cockpit/state/filings/medivation/medivation_2016-08-30_SCTO-T.htm:64).

**Internal consistency:** If C treats the full funds passage as the bid's financing state, Committed conflicts with E12's no-commitment override. On that premise, Contingent and Conditions = Heavy follow. Cash is only one source; the passage does not establish full payment from cash or existing facilities. Therefore, Not needed is not a required substitute.

**Source timing:** The “currently” passage does not expressly date all those facts to the August 20 bid. Its statement about absent commitments has retrospective wording. However, Part B still requires a connection to the bid's state within its window. The Note could describe a later state instead of the bid's state; its placement would then need separate review. Thus, the Note alone does not establish a contradictory bid-date classification.

**Instruction violation:** E10 does not permit C to copy August 8's Committed value into the revised $81.50 bid. If later transaction disclosures are excluded, the available bid account calls for Not stated. If the final disclosure is admitted as bid-state evidence, its adverse commitment language must receive E12 treatment too. A review cannot admit only the favorable half without a timing basis.

A and B use Not stated for the final bid and place funds information on the execution row. This shows a coherent treatment; it does not prove the only permitted treatment. The decisive finding is an unresolved evidence-window issue, not a source-proven Contingent bid on August 20.
